Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA Methylation Markers for Breast Cancer Detection in the Developing World
Bradley M. Downs, Claudia Mercado-Rodriguez, Ashley Cimino‐Mathews, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 21, pp. 6357-6367
Open Access | Times Cited: 25

Showing 25 citing articles:

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer
Xu Chen, Jingtong Zhang, Weimei Ruan, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 12, pp. 6278-6289
Open Access | Times Cited: 173
Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives
Joe Ibrahim, Marc Peeters, Guy Van Camp, et al.
European Journal of Cancer (2022) Vol. 178, pp. 91-113
Closed Access | Times Cited: 45
Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer
Xiaohong Mao, Qiang Ye, Guobing Zhang, et al.
World Journal of Surgical Oncology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries
Mary Jo Fackler, Madison Pleas, Youran Li, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
IL21R hypomethylation as a biomarker for distinguishing benign and malignant breast tumours
Zishan Zang, Yifei Yin, Chunlan Liu, et al.
Epigenetics (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
High performance methylated DNA markers for detection of colon adenocarcinoma
Romy A. M. Klein Kranenbarg, Abdul Hussain Vali, Jan N.M. IJzermans, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors
Bradley M. Downs, Wanjun Ding, Leslie Cope, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
Amal Ramadan, Maha Hashim, Amr Abouzid, et al.
Journal of Genetic Engineering and Biotechnology (2021) Vol. 19, Iss. 1, pp. 66-66
Open Access | Times Cited: 15
Comprehensive analysis based on DNA methylation and RNA-seq reveals hypermethylation of the up-regulated WT1 gene with potential mechanisms in PAM50 subtypes of breast cancer
Chongyang Ren, Xiaojiang Tang, Haitao Lan
PeerJ (2021) Vol. 9, pp. e11377-e11377
Open Access | Times Cited: 12
Exploring prognostic DNA methylation genes in bladder cancer: a comprehensive analysis
Jianzhong Zhang, Junyan Chen, M. Xu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer
Mary Jo Fackler, Suzana Tulač, Neesha Venkatesan, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 6, pp. 391-401
Open Access | Times Cited: 7
A Novel Promoter CpG-Based Signature for Long-Term Survival Prediction of Breast Cancer Patients
Yang Guo, Xiaoyun Mao, 真 高橋, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 9
Automated and rapid detection of cancer in suspicious axillary lymph nodes in patients with breast cancer
Juanjuan Li, Bradley M. Downs, Leslie Cope, et al.
npj Breast Cancer (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 7
Potential Role of AKR1B1 Gene Methylation in Diagnosis of Patients With Breast Cancer
Mohamed El‐Far, Mohamed A. Abdelrazek, Basma M. Foda, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access
Identification of cell-free circulating epigenomic biomarkers for early diagnosis and response to therapies in breast cancer patients
Pooja Ratre, Suresh Thareja, Pradyumna Kumar Mishra
International review of cell and molecular biology (2024), pp. 95-134
Closed Access
Screening and identification of hub-gene associated with brain metastasis in breast cancer
Xiaogang Li, Chao Niu, Ping Lu, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32771-e32771
Open Access | Times Cited: 1
Searching for DNA methylation in patients triple-negative breast cancer: a liquid biopsy approach
Irsa Shoukat, Christopher R. Mueller
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 1, pp. 41-51
Closed Access | Times Cited: 1
Conclusions and perspectives: Major challenges and future prospects for prognostic epigenetics
Shilpy Sharma
Elsevier eBooks (2019), pp. 397-409
Closed Access | Times Cited: 2
Introduction to biomarkers
Fariba Mollarasouli, Nurgül K. Bakırhan, Síbel A. Özkan
Elsevier eBooks (2021), pp. 1-22
Closed Access | Times Cited: 2
DNA methylation patterns of RAR‐β2 and RASSF1A gene promoters in FNAB samples from Greek population with benign or malignant breast lesions
Niki Kougioumtsidou, Εleftherios Vavoulidis, Maria Nasioutziki, et al.
Diagnostic Cytopathology (2020) Vol. 49, Iss. 1, pp. 153-164
Closed Access | Times Cited: 1
Special Ancillary Techniques: Immunohistochemistry
Gary M. Tse, Puay‐Hoon Tan, Fernando Schmitt
Springer eBooks (2023), pp. 155-162
Closed Access
High-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries
Mary Jo Fackler, Madison Pleas, Youran Li, et al.
Research Square (Research Square) (2023)
Open Access
Evaluating DNA Methylation in Random Fine Needle Aspirates from the Breast to Inform Cancer Risk
Kala Visvanathan, Ashley Cimino‐Mathews, Mary Jo Fackler, et al.
The Breast Journal (2022) Vol. 2022, pp. 1-7
Open Access
Epigenetic Contributions to Human Cancer
Stephen B. Baylin
Holland‐Frei Cancer Medicine (2022), pp. 1-13
Closed Access
An Innovative Integrative Method for Bladder Cancer Diagnosis
Hao Liu
BIO Integration (2021) Vol. 2, Iss. 3
Open Access
Page 1

Scroll to top